Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Daiichi Sankyo buys share of Ranbaxy

Daiichi Sankyo buys share of Ranbaxy

20th October 2008

Daiichi Sankyo has settled payment for a 20 per cent share of Indian company Ranbaxy Laboratories, it has been reported.

The third-largest drug manufacturer in Japan, based in Tokyo, has agreed the deal as part of an offer to buy a controlling share of Ranbaxy, Bloomberg said.

Daiichi Sankyo is expected to buy at least 50.1 per cent of the company by the end of the year for around 198 billion rupees (2.3 billion pounds), spokesperson Shigemichi Kondo said.

In June, Daiichi Sankyo’s chief executive Takashi Shoda agreed to purchase the controlling share of Ranbaxy – India’s largest drug maker – to enter the market for generic medicines.

Sales in this sector are growing nearly twice as quickly as the demand for branded drugs, the news source said.

Those looking for new scientific sales jobs may be interested in Daiichi Sankyo’s range of products, which includes Welchol, Azor, Floxin Benicar and Evoxac.


We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.